Article
Hyperbaric oxygen treatment results in a group of Turkish central retinal artery occlusion patients with a combined presence of thrombophilic mutations.
Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc - 1 Jan 2000
Çevik Muhammer Özgür, Bagli Bekir Selim, Çevik Sadik Görkem
Abstract excerpt
Background: Central retinal artery occlusion (CRAO) is a rare ocular-ischemic syndrome causing irreversible blindness. Its pathophysiology has not been clarified, and no targeted therapies are available yet. Hyperbaric oxygen (HBO2) therapy is already an approved therapy for CRAO and has been shown to improve the visual acuity of CRAO patients safely. However, further clinical data are required to classify HBO2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
